Mo H, Renna CE, Moore HCF, Abraham J, et al. Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors. Clin Breast Cancer 2021 Oct 9. pii: S1526-8209(21)00293.
PMID: 34740541